Is NICE (TASE:NICE) Cheap After Its CXone Rollout And AWS Cloud Partnership?
I'm LongbridgeAI, I can summarize articles.NICE (TASE:NICE) faces mixed sentiment following CXone AI platform rollout and an AWS European Sovereign Cloud partnership. While recent AI wins drove an 18.47% one-month price gain, the stock remains down significantly year-to-date. The dominant narrative suggests NICE is undervalued, with a fair value estimate of ₪620.96 against its current price of ₪298.9, citing strong AI ARR growth and cloud transition. However, risks include margin pressure from cloud investments and higher churn.
NICE (TASE:NICE) is back in focus after Sopra Steria rolled out the company’s CXone AI platform to more than 2,000 employees, and NICE joined the launch group for Amazon Web Services’ new European Sovereign Cloud.
See our latest analysis for NICE.
These new CXone deployments and the AWS European Sovereign Cloud launch partnership arrive as NICE’s ₪298.9 share price has seen a 1-month share price return of 18.47% but a year-to-date share price return that is down 17.73%, alongside a 1-year total shareholder return that is down 41.63%. This indicates near term momentum against a weaker multi year experience for holders.
If NICE’s recent AI wins have caught your attention, it could be a good moment to see what else is emerging in this space by scanning 63 profitable AI stocks that aren't just burning cash.
The recent bounce in NICE after its AI announcements raises a simple tension: has the rerating already captured most of the opportunity, or does the current valuation still leave meaningful upside if execution stays on track?
Most Popular Narrative: 51.9% Undervalued
The most followed narrative on NICE pegs fair value at ₪620.96 per share versus the last close at ₪298.9, framing a large valuation gap that rests heavily on how AI driven cloud demand plays out.
The rapid growth in demand for AI-driven customer experience solutions, manifested by 42% year-over-year growth in AI and self-service ARR and the upcoming integration of Cognigy's conversational AI capabilities, provides visibility into sustained increases in high-margin, recurring cloud revenue and expanded ARPU.
Ongoing acceleration in digital transformation and the shift from on-premise to cloud across global enterprises, underscored by major competitive wins and a solid pipeline of large-scale international deals (like DWP and AOK PLUS), support robust top-line growth and long-term increases in subscription revenues.
Read the complete narrative.
Want to see what sits behind that confidence in NICE? The narrative leans on steady revenue compounding, resilient margins, and a future earnings multiple that assumes investors will pay up for those cash flows over time.
Result: Fair Value of ₪620.96 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, for NICE, margin pressure from continued cloud investment and higher churn in acquired customers could challenge the AI upside that analysts are building into their forecasts.
Find out about the key risks to this NICE narrative.
Next Steps
Sentiment on NICE is clearly mixed, so if you feel the clock is ticking, go straight to the full breakdown of 4 key rewards and 1 important warning sign
Looking for more investment ideas beyond NICE?
If NICE has sharpened your focus on quality opportunities, do not stop here. Broaden your watchlist so you are not leaving potential ideas on the table.
- Target resilient compounding potential by scanning companies in the 212 high quality undervalued stocks that combine attractive prices with solid fundamentals.
- Prioritise capital preservation and steadier journeys by reviewing the 297 resilient stocks with low risk scores for stocks with lower overall risk profiles.
- Hunt for lesser known opportunities by checking the screener containing 499 high quality undiscovered gems that may not yet be crowded with attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if NICE might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free Analysis
